NextCell invited speaker at European Wound Management Association Meeting in Milan
NextCell Pharma AB´s ("NextCell" or the "Company") CSO, Dr Lindsay Davies, has been invited to give a presentation at the EWMA meeting in Milan, showcasing NextCell´s phase II clinical data with their investigative medicinal product, ProTrans, in slowing the progression of type-1 diabetes.Dr Davies, in addition to her role at NextCell, is a member of the scientific advisory board for the European Tissue Repair Society (ETRS). ETRS and EWMA have partnered for a session at the annual conference, that brings together wound management researchers, clinicians and industrial partners to discuss